Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Local Lidocaine Paravertebral Cervical Injection on Cervicogenic Dizziness Symptoms
Sponsor: Uniter Onlus
Summary
at least 42 patients affected by cervicogenic dizziness will be allocated to the experimental group or in the placebo group. in the first group patients will received 2 paravertebral intramuscular injection of lidocaine 0.5% while in the placebo group they will received saline solution with the same injection technique. patients will be evaluated by subjective and objective testing before the treatment, immediatly and 3 months after the treatment.
Official title: Usefullnes of Local Lidocaine Paravertebral Cervical Injection on Cervicogenic Dizziness Symptoms Management: a Randomzied Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
42
Start Date
2025-08-01
Completion Date
2025-09-15
Last Updated
2025-07-08
Healthy Volunteers
No
Conditions
Interventions
0.5% Lidocaine
0.5% lidocaine injection will be administered in the paravertebral intramuscular region with 12 mm, 30 G needle from C2 to C7 bilaterally
Saline Solution (NaCl 0,9%)
saline solution will be administered bilaterally in the paravertebral intamuscular region from C2 to C7 with 12 mm 30 G needle
Locations (1)
Uniter Onlus
Fara in Sabina, Rieti, Italy